We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Celator® Pharmaceuticals Raises $32.5 Million Completing a $39.3 Million Private Placement Financing

News   May 01, 2013

 
Celator® Pharmaceuticals Raises $32.5 Million Completing a $39.3 Million Private Placement Financing
 
 
 

RELATED ARTICLES

Immune Cells Double-check to Determine if Cells are Cancerous

News

Gamma Delta T cells possess a unique two-pronged device, allowing them to double-check whether the body's cells are healthy or dangerous before deciding whether to kill them.

READ MORE

Obesity and Cancer: ‘Fat-clogged’ Immune Cells Fail to Fight Tumors

News

Researchers have gained a new understanding of the link between obesity and cancer. In the presence of excess fat, the immune surveillance system fails due to an obesity-fueled lipid accumulation in natural killer (NK) cells, preventing their cellular metabolism and trafficking.

READ MORE

Solution to 125-Year-Old Neuroscience Mystery Provides Clues to Epilepsy Treatment

News

Scientists have solved a 125-year-old mystery of the brain, and, in the process, uncovered a potential treatment for acquired epilepsy.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE